The impact of COVID-19 on patients with IBD in a prospective European cohort study.

Aurélien AmiotJean-Francois RahierFilip BaertStephane NahonAilsa HartNikolaos ViazisLivia BianconeEugeni DomènechCatherine ReenearsLaurent Peyrin-BirouletLaurent BeaugerieJohan Burischnull null

Published in: Journal of Crohn's & colitis (2022)

No increase in either COVID-19 or severe COVID-19 incidences were observed in patients with IBD. There was no impact of COVID-19 on IBD-related medication and clinical activity. Access to endoscopy and imaging was restricted during the first months of the first COVID-19 outbreak.

Keyphrases

coronavirus disease
sars cov
respiratory syndrome coronavirus
healthcare
high resolution
early onset
emergency department
mass spectrometry
photodynamic therapy